3D Printed Drugs Market Size, Share & Trends Analysis Report By Technology (Inkjet Printing, Zipdose Technology, Stereolithography), By Application (Orthopedic, Neurology), By End-use, Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
3D Printed Drugs Market Growth & Trends
The global 3D printed drugs market is expected to reach USD 269.74 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030. The rising prevalence of chronic diseases, combined with the rising population of patients with dysphagia around the globe is pushing the demand for immediate soluble medications, which is likely to drive the market. For instance, according to a study published in April 2022, the prevalence of oropharyngeal dysphagia is high in conditions such as stroke and aging and is reported to be 26.19% in the elderly.
An increase in the aging population has led to the growing demand for the development of easy-to-swallow pills for the elderly. The 3D printed highly soluble and easy-to-swallow drugs can help the elderly who have difficulty swallowing. Moreover, according to the United Nations, the number of people aged 65 and more in 2050 is projected to be 1.5 billion. Thus, the growing elderly population across the world would propel the demand for easy-to-swallow drugs resulting in market growth.
Other factors such as quickly expanding demand for pharmaceuticals, technical improvements in healthcare, as well as the government's focus and expenditures in the 3D printing industry, are also contributing to the market's growth. For instance, in March 2022, Evonik Venture Capital invested in Nevada-based Laxxon Medical for the manufacturing of 3D-printed tablets. The latter company has developed a 3D screen-printing technology for the production of structured tablets with the controlled release of API over time. Such investments are likely to supplement the market growth in the coming years.
The COVID-19 pandemic is anticipated to positively impact market growth. Several printers have been launched by the operating companies in the advanced manufacturing industry to help increase the manufacturing of medications and other necessary products. As a result, the usage of these technologies is projected to increase during the COVID-19 pandemic.
The growing demand for personalized medicine is expected to majorly drive market growth in the coming years. As 3D printing of pharmaceutical drugs can produce personalized medicine in small batches with carefully tailored shapes, dosages, and sizes, the market is anticipated to grow at an exponential rate in the near future. In addition, the use of 3D printing technology can significantly reduce manufacturing costs thus, further increasing investments in this space.
On the other hand, adverse effects from these drugs, the use of 3D printing to create illegal drugs, and a lack of government restrictions for 3D printed products are limiting the market's growth. For instance, in March 2018, a police case was filed in Amsterdam, for the illegal handling of these drugs. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.
3D Printed Drugs Market Report Highlights
3D Printed Drugs Market Growth & Trends
The global 3D printed drugs market is expected to reach USD 269.74 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030. The rising prevalence of chronic diseases, combined with the rising population of patients with dysphagia around the globe is pushing the demand for immediate soluble medications, which is likely to drive the market. For instance, according to a study published in April 2022, the prevalence of oropharyngeal dysphagia is high in conditions such as stroke and aging and is reported to be 26.19% in the elderly.
An increase in the aging population has led to the growing demand for the development of easy-to-swallow pills for the elderly. The 3D printed highly soluble and easy-to-swallow drugs can help the elderly who have difficulty swallowing. Moreover, according to the United Nations, the number of people aged 65 and more in 2050 is projected to be 1.5 billion. Thus, the growing elderly population across the world would propel the demand for easy-to-swallow drugs resulting in market growth.
Other factors such as quickly expanding demand for pharmaceuticals, technical improvements in healthcare, as well as the government's focus and expenditures in the 3D printing industry, are also contributing to the market's growth. For instance, in March 2022, Evonik Venture Capital invested in Nevada-based Laxxon Medical for the manufacturing of 3D-printed tablets. The latter company has developed a 3D screen-printing technology for the production of structured tablets with the controlled release of API over time. Such investments are likely to supplement the market growth in the coming years.
The COVID-19 pandemic is anticipated to positively impact market growth. Several printers have been launched by the operating companies in the advanced manufacturing industry to help increase the manufacturing of medications and other necessary products. As a result, the usage of these technologies is projected to increase during the COVID-19 pandemic.
The growing demand for personalized medicine is expected to majorly drive market growth in the coming years. As 3D printing of pharmaceutical drugs can produce personalized medicine in small batches with carefully tailored shapes, dosages, and sizes, the market is anticipated to grow at an exponential rate in the near future. In addition, the use of 3D printing technology can significantly reduce manufacturing costs thus, further increasing investments in this space.
On the other hand, adverse effects from these drugs, the use of 3D printing to create illegal drugs, and a lack of government restrictions for 3D printed products are limiting the market's growth. For instance, in March 2018, a police case was filed in Amsterdam, for the illegal handling of these drugs. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.
3D Printed Drugs Market Report Highlights
- By technology, the zip dose segment held the largest share of the 3D market. This is attributed to the increase in the requirement for rapid soluble drugs that disperse quickly in the mouth, which in turn is likely to increase the adoption and anticipate market growth.
- The inkjet printer segment is expected to grow lucratively during the forecast period. Due to the 3D medications can be personalized to each patient's needs, assisting them far more than batch-produced medicines, their demand is expected to skyrocket in the coming years.
- By application, the neurology segment held a larger share of the global market. This is attributed to an increase in the proportion of older people, which is at an increased risk of developing neurological disorders and hence, propelling the market growth.
- By end-use, the hospitals & clinics segment held a larger share in 2021, owing to the growing demand for personalized medicines and the cost-effective use of bio-drugs employing this technology.
- North America dominated the global market in 2021 due to the availability of technologically advanced healthcare research framework, the presence of high R&D investment, and the development of 3D printed drugs in the region.
- The Asia Pacific is expected to grow considerably in the future owing to the rising prevalence of chronic diseases and the presence of key players.
- A few of the key market players include 3D Printer Drug Machine, Aprecia Pharmaceuticals, BV LLC, Hewlett Packard Caribe, and others.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL 3D PRINTED DRUGS MARKET VARIABLES, TRENDS, & SCOPE
4.1 3D Printed Drugs Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rising Usage Of 3D Printing In The Medical Industries
4.4.2 Increasing Adoption Of Personalized Drugs
4.4.3 Multiple Applications Of 3D Printing In Various Industries
4.4.4 High Demand For Instantaneous Soluble Tablets
4.4.5 Outbreak Of Covid-19
4.5 Market Restraint Analysis
4.5.1 Limitations Of 3D Printed Medicines
4.5.2 Lack Of Government Regulations For 3D Printed Products
4.6 Market Opportunity Analysis
4.6.1 Rising Awareness And Adoption Of The 3D Printing Technology
4.7 Porter’s Five Forces Analysis
4.8 Pipeline Analysis
CHAPTER 5 3D PRINTED MARKET - SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
5.1 Global 3D Printed Drugs Market: Technology Movement Analysis
5.2 Inkjet Printing
5.2.1 Inkjet Printing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Fused Deposition Modeling
5.3.1 Fused Deposition Modeling Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Stereolithography
5.4.1 Stereolithography Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 ZipDose Technology
5.5.1 Zipdose Technology Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 3D PRINTED DRUGS MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
6.1 Global 3D Printed Drugs Market: Application Movement Analysis
6.2 Orthopedic
6.2.1 Orthopedic Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Neurology
6.3.1 Neurology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Dental
6.4.1 Dental Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 3D PRINTED DRUGS MARKET- SEGMENT ANALYSIS, BY END-USER, 2018 - 2030 (USD MILLION)
7.1 3D Printed Drugs Market: End-User Movement Analysis
7.2 Hospitals & Clinics
7.2.1 Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Research Laboratories
7.3.1 Research Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Others
7.4.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 3D PRINTED DRUGS MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 3D Printed Drugs Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4 Spain
8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5 France
8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Market Estimates And Forecast, 2018 - 2030
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market estimates and forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 APRECIA PHARMACEUTICALS LLC
9.3.1.1 Company Overview
9.3.1.2 Alere, Inc.
9.3.1.3 Financial Performance
9.3.1.4 Product Benchmarking
9.3.1.5 Strategic Initiatives
9.3.2 EXTEND BIOSCIENCES
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 BIODURO
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 AFFINITY THERAPEUTICS
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 OSMOTICA PHARMACEUTICALS
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 ACRUX
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 GLAXOSMITHKLINE PLC
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 HEWLETT PACKARD CARIBE
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 MERCK
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 CYCLE PHARMACEUTICALS
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 ASTRAZENECA
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 FABRX LTD.
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary
CHAPTER 4 GLOBAL 3D PRINTED DRUGS MARKET VARIABLES, TRENDS, & SCOPE
4.1 3D Printed Drugs Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rising Usage Of 3D Printing In The Medical Industries
4.4.2 Increasing Adoption Of Personalized Drugs
4.4.3 Multiple Applications Of 3D Printing In Various Industries
4.4.4 High Demand For Instantaneous Soluble Tablets
4.4.5 Outbreak Of Covid-19
4.5 Market Restraint Analysis
4.5.1 Limitations Of 3D Printed Medicines
4.5.2 Lack Of Government Regulations For 3D Printed Products
4.6 Market Opportunity Analysis
4.6.1 Rising Awareness And Adoption Of The 3D Printing Technology
4.7 Porter’s Five Forces Analysis
4.8 Pipeline Analysis
CHAPTER 5 3D PRINTED MARKET - SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
5.1 Global 3D Printed Drugs Market: Technology Movement Analysis
5.2 Inkjet Printing
5.2.1 Inkjet Printing Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Fused Deposition Modeling
5.3.1 Fused Deposition Modeling Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Stereolithography
5.4.1 Stereolithography Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 ZipDose Technology
5.5.1 Zipdose Technology Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 3D PRINTED DRUGS MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
6.1 Global 3D Printed Drugs Market: Application Movement Analysis
6.2 Orthopedic
6.2.1 Orthopedic Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Neurology
6.3.1 Neurology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Dental
6.4.1 Dental Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 3D PRINTED DRUGS MARKET- SEGMENT ANALYSIS, BY END-USER, 2018 - 2030 (USD MILLION)
7.1 3D Printed Drugs Market: End-User Movement Analysis
7.2 Hospitals & Clinics
7.2.1 Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Research Laboratories
7.3.1 Research Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Others
7.4.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 3D PRINTED DRUGS MARKET: - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 3D Printed Drugs Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4 Spain
8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5 France
8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Market Estimates And Forecast, 2018 - 2030
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market estimates and forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 APRECIA PHARMACEUTICALS LLC
9.3.1.1 Company Overview
9.3.1.2 Alere, Inc.
9.3.1.3 Financial Performance
9.3.1.4 Product Benchmarking
9.3.1.5 Strategic Initiatives
9.3.2 EXTEND BIOSCIENCES
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 BIODURO
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 AFFINITY THERAPEUTICS
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 OSMOTICA PHARMACEUTICALS
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 ACRUX
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 GLAXOSMITHKLINE PLC
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 HEWLETT PACKARD CARIBE
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 MERCK
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 CYCLE PHARMACEUTICALS
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 ASTRAZENECA
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 FABRX LTD.
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
LIST OF TABLES
TABLE 1 List of Secondary Sources
TABLE 2 Regulatory Framework
TABLE 3 Global 3D printed drugs market estimates and forecasts by technology, 2018 - 2030 (USD Million)
TABLE 4 Global 3D printed drugs market estimates and forecasts by application, 2018 - 2030 (USD Million)
TABLE 5 3D printed drugs- Key market restraint
TABLE 6 Global 3D printed drugs inkjet printing market by region, 2018 - 2030 (USD Million)
TABLE 7 Global 3D printed drugs fused deposition modeling market by region, 2018 - 2030 (USD Million)
TABLE 8 Global 3D printed drugs stereolithography market by region, 2018 - 2030 (USD Million)
TABLE 9 Global 3D printed drugs ZipDose technology market by region, 2018 - 2030 (USD Million)
TABLE 10 Global 3D printed drugs demand in orthopedic by region, 2018 - 2030 (USD Million)
TABLE 11 Global 3D printed drugs demand in neurology by region, 2018 - 2030 (USD Million)
TABLE 12 Global 3D printed drugs demand in dental by region, 2018 - 2030 (USD Million)
TABLE 13 Global 3D printed drugs demand in other applications by region, 2018 - 2030 (USD Million)
TABLE 14 Global 3D printed drugs demand in hospitals & clinics by region, 2018 - 2030 (USD Million)
TABLE 15 Global 3D printed drugs demand in research laboratories by region, 2018 - 2030 (USD Million)
TABLE 16 Global 3D printed drugs demand in other end-use by region, 2018 - 2030 (USD Million)
TABLE 17 North America 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 18 North America 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 19 North America 3D printed drugs market by end-use, 2018 - 2030 (USD Million)
TABLE 20 U.S. 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 21 U.S. 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 22 U.S. 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 23 Canada 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 24 Canada 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 25 Canada 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 26 Europe 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 27 Europe 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 28 Europe 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 29 Germany 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 30 Germany 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 31 Germany 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 32 U.K. 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 33 U.K. 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 34 U.K. 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 35 France 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 36 France 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 37 France 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 38 Italy 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 39 Italy 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 40 Italy 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 41 Spain 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 42 Spain 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 43 Spain 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 44 Asia Pacific 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 45 Asia Pacific 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 46 Asia Pacific 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 47 China 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 48 China 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 49 China 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 50 India 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 51 India 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 52 India 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 53 Japan 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 54 Japan 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 55 Japan 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 56 South Korea 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 57 South Korea 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 58 South Korea 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 59 Latin America 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 60 Latin America 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 61 Latin America 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 62 Brazil 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 63 Brazil 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 64 Brazil 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 65 Mexico 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 66 Mexico 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 67 Mexico 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 68 MEA 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 69 MEA 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 70 MEA 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 71 South Africa 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 72 South Africa 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 73 South Africa 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 74 Saudi Arabia 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 75 Saudi Arabia 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 76 Saudi Arabia 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 1 List of Secondary Sources
TABLE 2 Regulatory Framework
TABLE 3 Global 3D printed drugs market estimates and forecasts by technology, 2018 - 2030 (USD Million)
TABLE 4 Global 3D printed drugs market estimates and forecasts by application, 2018 - 2030 (USD Million)
TABLE 5 3D printed drugs- Key market restraint
TABLE 6 Global 3D printed drugs inkjet printing market by region, 2018 - 2030 (USD Million)
TABLE 7 Global 3D printed drugs fused deposition modeling market by region, 2018 - 2030 (USD Million)
TABLE 8 Global 3D printed drugs stereolithography market by region, 2018 - 2030 (USD Million)
TABLE 9 Global 3D printed drugs ZipDose technology market by region, 2018 - 2030 (USD Million)
TABLE 10 Global 3D printed drugs demand in orthopedic by region, 2018 - 2030 (USD Million)
TABLE 11 Global 3D printed drugs demand in neurology by region, 2018 - 2030 (USD Million)
TABLE 12 Global 3D printed drugs demand in dental by region, 2018 - 2030 (USD Million)
TABLE 13 Global 3D printed drugs demand in other applications by region, 2018 - 2030 (USD Million)
TABLE 14 Global 3D printed drugs demand in hospitals & clinics by region, 2018 - 2030 (USD Million)
TABLE 15 Global 3D printed drugs demand in research laboratories by region, 2018 - 2030 (USD Million)
TABLE 16 Global 3D printed drugs demand in other end-use by region, 2018 - 2030 (USD Million)
TABLE 17 North America 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 18 North America 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 19 North America 3D printed drugs market by end-use, 2018 - 2030 (USD Million)
TABLE 20 U.S. 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 21 U.S. 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 22 U.S. 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 23 Canada 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 24 Canada 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 25 Canada 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 26 Europe 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 27 Europe 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 28 Europe 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 29 Germany 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 30 Germany 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 31 Germany 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 32 U.K. 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 33 U.K. 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 34 U.K. 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 35 France 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 36 France 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 37 France 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 38 Italy 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 39 Italy 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 40 Italy 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 41 Spain 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 42 Spain 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 43 Spain 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 44 Asia Pacific 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 45 Asia Pacific 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 46 Asia Pacific 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 47 China 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 48 China 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 49 China 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 50 India 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 51 India 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 52 India 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 53 Japan 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 54 Japan 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 55 Japan 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 56 South Korea 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 57 South Korea 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 58 South Korea 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 59 Latin America 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 60 Latin America 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 61 Latin America 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 62 Brazil 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 63 Brazil 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 64 Brazil 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 65 Mexico 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 66 Mexico 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 67 Mexico 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 68 MEA 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 69 MEA 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 70 MEA 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 71 South Africa 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 72 South Africa 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 73 South Africa 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
TABLE 74 Saudi Arabia 3D printed drugs market by technology, 2018 - 2030 (USD Million)
TABLE 75 Saudi Arabia 3D printed drugs market by application, 2018 - 2030 (USD Million)
TABLE 76 Saudi Arabia 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 3D printed drugs market segmentation
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Market formulation & validation
FIG. 6 Commodity flow analysis
FIG. 7 3D printed drugs market snapshot (2021)
FIG. 8 Market segmentation
FIG. 9 Penetration & growth prospect mapping
FIG. 10 Consumer behavior analysis
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Porter’s five forces analysis
FIG. 15 3D printed drugs market technology outlook: Segment dashboard
FIG. 16 3D printed drugs market: Technology movement analysis
FIG. 17 Inkjet printing market, 2018 - 2030 (USD Million)
FIG. 18 Fused deposition modeling market, 2018 - 2030 (USD Million)
FIG. 19 Stereolithography market, 2018 - 2030 (USD Million)
FIG. 20 ZipDose Technology market, 2018 - 2030 (USD Million)
FIG. 21 3D printed drugs market application outlook: Segment dashboard
FIG. 22 3D printed drugs market: Application movement analysis
FIG. 23 Orthopedic market, 2018 - 2030 (USD Million)
FIG. 24 Neurology market, 2018 - 2030 (USD Million)
FIG. 25 Dental market, 2018 - 2030 (USD Million)
FIG. 26 Other applications market, 2018 - 2030 (USD Million)
FIG. 27 3D printed drugs market end-user outlook: Segment dashboard
FIG. 28 3D printed drugs market: End-user movement analysis
FIG. 29 Hospitals & clinics market, 2018 - 2030 (USD Million)
FIG. 30 Research laboratories market, 2018 - 2030 (USD Million)
FIG. 31 Other end-users market, 2018 - 2030 (USD Million)
FIG. 32 Regional market: Key takeaways
FIG. 33 Regional outlook, 2021 & 2030
FIG. 34 North America 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 35 U.S. 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 36 Canada 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 37 Europe 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 38 U.K. 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 39 Germany 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 40 France 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 41 Italy 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 42 Spain 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 43 Asia Pacific 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 44 Japan 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 45 China 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 46 India 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 47 South Korea 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 48 Latin America 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 49 Brazil 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 50 Mexico 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 51 MEA 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 52 South Africa 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 53 Saudi Arabia 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 1 3D printed drugs market segmentation
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Market formulation & validation
FIG. 6 Commodity flow analysis
FIG. 7 3D printed drugs market snapshot (2021)
FIG. 8 Market segmentation
FIG. 9 Penetration & growth prospect mapping
FIG. 10 Consumer behavior analysis
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Porter’s five forces analysis
FIG. 15 3D printed drugs market technology outlook: Segment dashboard
FIG. 16 3D printed drugs market: Technology movement analysis
FIG. 17 Inkjet printing market, 2018 - 2030 (USD Million)
FIG. 18 Fused deposition modeling market, 2018 - 2030 (USD Million)
FIG. 19 Stereolithography market, 2018 - 2030 (USD Million)
FIG. 20 ZipDose Technology market, 2018 - 2030 (USD Million)
FIG. 21 3D printed drugs market application outlook: Segment dashboard
FIG. 22 3D printed drugs market: Application movement analysis
FIG. 23 Orthopedic market, 2018 - 2030 (USD Million)
FIG. 24 Neurology market, 2018 - 2030 (USD Million)
FIG. 25 Dental market, 2018 - 2030 (USD Million)
FIG. 26 Other applications market, 2018 - 2030 (USD Million)
FIG. 27 3D printed drugs market end-user outlook: Segment dashboard
FIG. 28 3D printed drugs market: End-user movement analysis
FIG. 29 Hospitals & clinics market, 2018 - 2030 (USD Million)
FIG. 30 Research laboratories market, 2018 - 2030 (USD Million)
FIG. 31 Other end-users market, 2018 - 2030 (USD Million)
FIG. 32 Regional market: Key takeaways
FIG. 33 Regional outlook, 2021 & 2030
FIG. 34 North America 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 35 U.S. 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 36 Canada 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 37 Europe 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 38 U.K. 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 39 Germany 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 40 France 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 41 Italy 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 42 Spain 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 43 Asia Pacific 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 44 Japan 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 45 China 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 46 India 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 47 South Korea 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 48 Latin America 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 49 Brazil 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 50 Mexico 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 51 MEA 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 52 South Africa 3D printed drugs market, 2018 - 2030 (USD Million)
FIG. 53 Saudi Arabia 3D printed drugs market, 2018 - 2030 (USD Million)
